Delaware is the US’s go-to venue for pharma patent litigation, but there could be trouble ahead

@IAM_Alerts RT @marconi: Last week, our @Avanci colleague Luke McLeroy spoke at @IAM_Alerts' #AutoIPUSA event in Detroit. On Nov 2, Laurie Fitzgerald… Read more

@IAM_Alerts After a tough 2020 for med-tech deal-making, diagnostic innovation buyouts are driving a resurgence in IP-rich acqu… https://t.co/M44uKPtagj Read more

@IAM_Alerts Ericsson posts strong licensing quarter as it heads into an all-important renewal with Apple https://t.co/xbbxWFsscH https://t.co/KZpjln1pcM Read more

@IAM_Alerts RT @AMorrisReports: VideoLabs has found it tough to build industry support for its membership model during the covid pandemic and a new dec… Read more